Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients.
Moghadam P, Tancrede E, Bouaziz JD, Kallout J, Bedane C, Begon E, Bourgault-Villada I, Calugareanu A, Dereure O, Jendoubi F, Pham-Ledard A, Ingen-Housz-Oro S, Picard-Dahan C, Viguier M, Mahevas T, Jachiet M, Charvet E, Cassius C, Alexandre M, Lepelletier C. Moghadam P, et al. Among authors: jendoubi f. Br J Dermatol. 2023 Jul 17;189(2):244-246. doi: 10.1093/bjd/ljad136. Br J Dermatol. 2023. PMID: 37155583 No abstract available.
Severe pemphigoid nodularis successfully treated with dupilumab.
Jendoubi F, Bost C, Tournier E, Paul C, Konstantinou MP. Jendoubi F, et al. Dermatol Ther. 2022 Sep;35(9):e15727. doi: 10.1111/dth.15727. Epub 2022 Jul 31. Dermatol Ther. 2022. PMID: 35861645 Free PMC article. No abstract available.
Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study.
Jendoubi F, Shourik J, Seneschal J, Giordano-Labadie F, Raison-Peyron N, Du-Thanh A, Tetart F, Valois A, Droitcourt C, Clément A, Nosbaum A, Crepy MN, Jachiet M, Bouaziz JD, Bernier C, Soria A, Paul C, Barbarot S, Tauber M; GREAT network (Groupe de Recherche sur l’Eczema ATopique of the French Society of Dermatology). Jendoubi F, et al. Br J Dermatol. 2022 Oct;187(4):602-603. doi: 10.1111/bjd.21628. Epub 2022 Jul 11. Br J Dermatol. 2022. PMID: 35481677 Free PMC article. No abstract available.
A Multicentre Randomised Controlled Study Evaluating the Effect of a Standardised Education Programme on Quality of Life, Disease Severity, and Disease Knowledge in Patients with Moderate-To-Severe Psoriasis: The EDUPSO Study.
Jendoubi F, Balica S, Richard MA, Chiaverini C, Bernier C, Quiles N, Bachelez H, Beylot-Barry M, Mallet S, Goujon C, Parier J, Misery L, Carrere F, Lauwers-Cances V, Paul C; French Psoriasis Research Group. Jendoubi F, et al. Dermatology. 2022;238(4):630-639. doi: 10.1159/000520289. Epub 2021 Dec 9. Dermatology. 2022. PMID: 34883480 Clinical Trial.
24 results